Healthcare stock Abacus Health Products develops and commercializes over-the-counter topical pain relief and therapeutic skincare products.
Abacus Health Products Inc. (CNSX—ABCS) is poised to become a leader in the topical pain   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

“Being able to perform in line or better than the market while holding almost a third in cash suggests that our stock picking and trading strategy have provided positive alpha   Read More

Consumer goods stock Johnson & Johnson faces a public relations nightmare that could cost it billions. From a purely financial viewpoint, however, this global stock remains a buy.
US stock Johnson   Read More

Analyst Alp Erdogan says that in 2019, capital that bloated the 2018 prices of cryptocurrencies, cannabis stocks and blockchain technology generally will shift toward value stocks with better defensive characteristics.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Canntab Therapeutics Inc. has developed a process to incorporate cannabis extracts into pills that administer measured, standardized dosages, and include a unique delivery system to enable time-controlled absorption. Investor’s Digest   Read More

Open Text has improved the quality of its revenues by increasing the amount of recurring revenues it earns. Higher-quality revenues should help it to continue to deliver the cash flows   Read More

Vancouver-based PI Financial Corp. analysts Bob Gibson, Jason Zandberg and Devin Schilling recently teamed up to review their most recent list of ‘top stock picks’ for Investor’s Digest of Canada.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Investor’s Digest of Canada contributors Doug Cooper and David Kideckel, Toronto-based Beacon Securities equity analysts, argue the United States is in the midst of a pot revolution. Americans are hankering   Read More

A junior marijuana start-up has just closed a deal to buy an enormous former food plant facility in Cobourg, Ontario, that spans 27 acres and once manufactured cereals, dog food,   Read More

‘Where there’s smoke, there’s . . . opportunity’ concludes The MoneyLetter after surveying a number of security analysts’ reports on medical cannabis producers in Canada. Companies already established in the   Read More

Cardinal Health’s problems with Cordis, plus the negative impact of generic drug pricing on company profits, has given us pause on this healthcare stock. We recommend that purchases be deferred   Read More

A mouse trap it isn’t, but the world’s Holter monitor wearers may want to beat a path to the door of medical technology stock iRhythm Technologies Inc., a digital health   Read More

A number of established medical marijuana producers are preparing themselves for expansion and entry into the soon-to-be-legal recreational marijuana market. The MoneyLetter recently surveyed a number of security analysts’ reports   Read More

PI Financial analysts Devin Schilling and Jason Zandberg are ‘fired up’ about a new supplier of medical cannabis, whose mission, in turn, is to ‘light up’ the cannabis sector.
BC-based   Read More

With the rapid rise of US stock prices these past several years, it has become increasingly difficult to find reasonably valued stocks in the US market. Here are three stocks   Read More

Investor’s Digest recently reported on Calgary-based Acumen Capital analysts Brian Pow, Nick Corcoran and Ted Bobier’s five favourite growth stock candidates for 2018.
Early trading in 2018 showed strong market   Read More

It’s best to diversify your portfolio across all five sectors of the economy: finance, utilities, consumer, manufacturing and resources. Remember, though, there’s danger in loading up on stocks in sectors   Read More

We expect consumer stock Walgreens Boots Alliance to deliver long-term share price gains. We also expect this ‘dividend aristocrat’ to continue to raise its dividend each year. And we further   Read More

Many financial analysts will argue that medical marijuana producers are bargain stocks today. But one such bargain stock that Mackie Research analyst Greg McLeish recommends is a bargain that he   Read More

Many financial analysts will argue that medical marijuana producers are bargain stocks today. But one such bargain stock that Mackie Research analyst Greg McLeish recommends is a bargain that he   Read More

Seniors housing and business software technology may make for an odd couple on anybody’s ‘best of anything’ list. But chartered financial analyst Christine Poole sees money to be made from   Read More

Blue-chip consumer goods stock Metro Inc. has agreed to acquire drugstore chain Jean Coutu Group. We think that Metro will profit from this transaction. It remains a buy. Coutu’s shares   Read More

Four times a year The Investment Reporter reviews its outlook for the economy’s five main sectors—financial, utilities, manufacturing, consumer and resources. Its guiding rule is that investors keep at least   Read More

US stock Cardinal Health did well in the year to June 30. This year it’s expected to struggle. But the shares are cheap for a blue chip stock that rewards   Read More

Beacon Securities head of research, Toronto-based Doug Cooper, analyzed New Look Vision Group’s latest acquisition and concluded that the transaction not only grows New Look’s store count by about 66   Read More

‘Le jour de gloire est arrivé,’ according to Equium Capital Management president Cameron Hurst. Mr. Hurst sees more stability in Germany and riskier opportunities in Italy and Spain, but he   Read More

Cyclical investing works if the timing is right. The key question is: “Is this the right time?” Our current expansion (begun in 2009) is getting long in the tooth. Sectors   Read More

The S&P/TSX hasn’t shared in the current strength of global stock markets. In fact, the Toronto market has lost ground since it reached an all-time high in February. Only a   Read More

Portfolio manager Lorne Zeiler picks a US-based global healthcare stock and a Canadian preferred share exchange traded fund as his current two ‘best buys’ for investors seeking high dividend income   Read More

Hero today, Zero tomorrow. That’s how ValueTrend portfolio manager Keith Richards reminds himself that sector rotation is becoming faster and more pronounced of late. So who’s hot, and who’s not?   Read More

Medtronic PLC is a medical technology stock. It earned record profits in the year ended April 28. It’s expected to earn record profits in fiscal 2018 (which began April 29)   Read More

When you buy stocks in sectors and sub-sectors of the market, keep your portfolio balance goals in mind. If you’re a conservative, income-seeking investor, focus on utilities, financial and consumer   Read More

We’ve added Beutel Goodman American Equity to our list of ‘The Top 40: Canada’s Best Mutual Funds’ in the category of recommended equity mutual funds that invest mainly in U.S.   Read More

Another player recently joined the rapidly growing list of publicly-traded marijuana stocks in Canada. Writing in Investor’s Digest of Canada, Zachary McCrossin says WeedMD Inc.’s chief executive officer has a   Read More

Sentry Investments executive Andy Nasr looks to the United States, especially the financial, consumer staples, healthcare, technology, construction and infrastructure sectors, as good places to invest now. When pressed to   Read More

Healthcare stock Emblem Corp. is a Canadian licensed producer of medical marijuana, providing patients with high-quality, premium cannabis strains. It has recently sourced a supply of high-cannabidiol marijuana from a   Read More

A pullback is unlikely to sink a strong bull market in equities, yet it could offer investors an ideal opportunity to increase exposure to a sector of the market that   Read More

An infrastructure stock and a healthcare stock sound like an odd couple for investment counsellor Robert Sneddon’s two ‘best buy’ stock selections. But Mr. Sneddon forecasts a strong bull run   Read More

Dominant global technology stock Alphabet Inc. (parent of Google) and renewable energy stock Algonquin Power and Utilities are the two best stocks to buy now says Toronto-based Sentry Investments analyst   Read More

Gold and gold mining stocks will benefit from the turbulence of the Trump presidency. And, analyst David Chapman writes in Investor’s Digest of Canada, the amount of new gold being   Read More

Continue to add to your Canadian equity mutual funds portfolio. Aggressive small-cap equity mutual funds are starting to reward risk takers now.
Economic data and market sentiment have improved in recent   Read More

Canopy Growth is a diversified cannabis company engaged in growing and distributing medical marijuana products to patients across Canada. Mettrum Health Corp. is also a producer of medical cannabis and   Read More

Dominant global technology stock Alphabet Inc. (parent of Google) and renewable energy stock Algonquin Power and Utilities are the two best stocks to buy now says Toronto-based Sentry Investments analyst   Read More

Regular MoneyLetter columnist John Stephenson offers his stock market outlook for the early days of a Trump administration. Financial stocks should be among the first big winners because of the   Read More

American Depositary Receipts, or ADRs, give you benefits. One is global portfolio diversification. It’s tempting to call ADRs American ‘Diversification’ Receipts. They give you industries that Canada lacks or has   Read More

Loblaw Companies is a very conservative defensive consumer stock with a low beta of 0.518 which makes it an excellent choice for income investors seeking stocks that are considerably less   Read More

Sentry Investments analyst Andy Nasr identifies two U.S. stocks that will continue to prosper regardless of the U.S. election results. One is a pharmacy operator popular with drugstore-cowboy seniors. The   Read More

Follow the money into cyclical emerging markets or hunker down with some steady defensive stalwarts? The MoneyLetter’s regular investment strategy columnist John Stephenson recommends a combination of two emerging market   Read More